Literature DB >> 27794111

Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy.

Haruki Koike1, Shohei Ikeda2, Mie Takahashi2, Yuichi Kawagashira2, Masahiro Iijima2, Yohei Misumi2, Yukio Ando2, Shu-Ichi Ikeda2, Masahisa Katsuno2, Gen Sobue1.   

Abstract

OBJECTIVE: To examine the morphology of Schwann cells and endoneurial microvessels with electron microscopy.
METHODS: Sural nerve biopsy specimens from 49 patients with familial amyloid polyneuropathy (FAP) with transthyretin Val30Met mutation were assessed. Patients included 11 early-onset cases from endemic foci and 38 late-onset cases from nonendemic areas.
RESULTS: Loss of nerve fibers with or without neighboring amyloid deposition was a common feature. The amount of amyloid deposition was greater relative to the extent of nerve fiber loss in early-onset cases than in late-onset cases. The atrophy of Schwann cells, particularly nonmyelinating Schwann cells, that were apposed to amyloid fibrils was more conspicuous in early-onset cases than in late-onset cases. The numbers of endothelial cell nuclei, endothelial cell profiles, and occluded microvessels were significantly increased in the patients with FAP compared with 37 patients with nutritional/alcoholic neuropathies (p < 0.05, 0.01, and 0.01, respectively). Findings suggestive of the disruption of blood-nerve barriers such as the loss of tight junctions and the fenestration of endothelial cells were also found more frequently in the patients with FAP (p < 0.001), regardless of the presence or absence of amyloid deposition.
CONCLUSIONS: These findings suggest that direct insult of amyloid fibrils causes Schwann cell damage, resulting in the predominant loss of small-fiber axons characteristic of early-onset cases. In addition, vasculopathy may participate in the pathogenesis of neuropathy, particularly in late-onset cases.
© 2016 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27794111     DOI: 10.1212/WNL.0000000000003362

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

1.  Patterns of myelinated nerve fibers loss in transthyretin amyloid polyneuropathy and mimics.

Authors:  Kang Du; Xujun Chu; Yuwei Tang; Xutong Zhao; Meng Yu; Yiming Zheng; Jianwen Deng; He Lv; Wei Zhang; Zhaoxia Wang; Yun Yuan; Lingchao Meng
Journal:  Ann Clin Transl Neurol       Date:  2022-06-04       Impact factor: 5.430

Review 2.  The role of transthyretin in cell biology: impact on human pathophysiology.

Authors:  Joana Magalhães; Márcia Almeida Liz; Jessica Eira
Journal:  Cell Mol Life Sci       Date:  2021-07-23       Impact factor: 9.261

Review 3.  Transthyretin familial amyloid polyneuropathy: an update.

Authors:  Violaine Plante-Bordeneuve
Journal:  J Neurol       Date:  2017-12-16       Impact factor: 4.849

4.  Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.

Authors:  Haruki Koike; Tomohiko Nakamura; Atsushi Hashizume; Ryoji Nishi; Shohei Ikeda; Yuichi Kawagashira; Masahiro Iijima; Masahisa Katsuno; Gen Sobue
Journal:  J Neurol       Date:  2017-10-05       Impact factor: 4.849

Review 5.  Multidisciplinary Approaches for Transthyretin Amyloidosis.

Authors:  Haruki Koike; Takahiro Okumura; Toyoaki Murohara; Masahisa Katsuno
Journal:  Cardiol Ther       Date:  2021-06-04

6.  Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy.

Authors:  Andrea Cortese; Elisa Vegezzi; Alessandro Lozza; Enrico Alfonsi; Alessandra Montini; Arrigo Moglia; Giampaolo Merlini; Laura Obici
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-02-10       Impact factor: 10.154

7.  Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system.

Authors:  Nádia Pereira Gonçalves; João Moreira; Diana Martins; Paulo Vieira; Laura Obici; Giampaolo Merlini; Margarida Saraiva; Maria João Saraiva
Journal:  J Neuroinflammation       Date:  2017-06-06       Impact factor: 8.322

8.  Anterior Chamber Flare as an Objective and Quantitative Noninvasive Method for Oculopathy in Transthyretin V30M Amyloidosis Patients.

Authors:  João Beirão; Vasco Miranda; Beatriz Pinheiro-Torres; João Coelho; Maria-João Menéres; Pedro Menéres
Journal:  J Ophthalmol       Date:  2018-09-20       Impact factor: 1.909

Review 9.  Advances in the treatment of hereditary transthyretin amyloidosis: A review.

Authors:  Morie A Gertz; Michelle L Mauermann; Martha Grogan; Teresa Coelho
Journal:  Brain Behav       Date:  2019-08-01       Impact factor: 2.708

Review 10.  Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.

Authors:  Yoshiki Sekijima; Mitsuharu Ueda; Haruki Koike; Sonoko Misawa; Tomonori Ishii; Yukio Ando
Journal:  Orphanet J Rare Dis       Date:  2018-01-17       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.